Business Standard

Monday, December 23, 2024 | 01:36 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Chennai Covishield volunteer to move court against Serum Institute

Serum Institute of India said the volunteer was "falsely laying the blame for his medical problems on the vaccine trial"

Serum institute, coronavirus, vaccine, pharma, drugs
Premium

SII produces 1.5 billion annual dosages for polio, diphtheria, tetanus, BCG among other vaccines

T E Narasimhan Chennai
The 40-year-old Chennai volunteer, who had earlier sent a legal notice to the Pune-based Serum Institute of India (SII) against its Covishield vaccine trial, has decided to move court.

Earlier, he had sent a legal notice seeking ~5 crore in damages, alleging he had developed severe neurological complications and impaired cognitive functions after he took the first jab, for which SII is seeking marketing authorisation from the Indian regulator.

R Rajaram, one of the advocates for the volunteer's family, told Business Standard that they are preparing the writ petition and will be moving court in the next few

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in